Advances in Clinical and Experimental Medicine

Adv Clin Exp Med
Impact Factor (IF) – 1.227
Index Copernicus (ICV 2018) – 157.72
MNiSW – 40
Average rejection rate – 84.38%
ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download PDF

Advances in Clinical and Experimental Medicine

2015, vol. 24, nr 4, July-August, p. 657–662

doi: 10.17219/acem/41070

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Prostate and Bladder Cancer Coexistence in Patients Undergoing Radical Cystoprostatectomy

Janusz Dembowski1,A,D,F, Paweł Hackemer1,A,B,D,F, Amadeusz Winkler1,B,C, Anna Otlewska1,B,C, Krzysztof Tupikowski1,C, Romuald Zdrojowy1,E

1 Department of Urology and Oncological Urology, Wroclaw Medical University, Poland

Abstract

Background. According to the Polish National Cancer Registry, bladder cancer is the 4th most common cancer in the male population (7.0%), while prostate cancer takes 2nd place (14.0%). In the case of both cancer types, prognoses are precarious and depend on many factors, such as the size of the primary tumor, infiltration of regional lymph nodes, histological grade and occurrence of distant metastases.
Objectives. The objective of this work is to verify the coincidence of prostate cancer and bladder cancer in patients who underwent radical cystoprostatectomy in Wroclaw Medical University, Department of Urology and Oncological Urology, as well as to indicate factors that may influence the periand post-operative course.
Material and Methods. We have retrospectively reviewed patients who underwent radical cystoprostatectomy for muscular-invasive bladder cancer between 2009 and 2014, which comprised of 116 male patients. We managed to establish telephone and personal contact with the patients.
Results. Seventeen of the 116 patients were diagnosed with coincidental prostate cancer in post-operative histological examination (14.6%). This result is lower than in other series of cystoprostatectomy cases (range 23–68%). The mean age of patient was 68.9 years and the median was 69.5 years. Factors influencing the periand post-operative periods were not statistically significant.
Conclusion. Serum PSA level and DRE should be performed more often on patients prepared for radical cystoprostatectomy. An accurate pre-operative assessment of cancer infiltration is required for both types of tumors. Complete resection of prostate prevents residual neoplasm infiltration. It is important to take into account the possibility of primary prostate tumor occurrence in patients qualified for radical cystectomy. The post-operative supervision should be focused not only on bladder carcinoma but on the prostate carcinoma, too.

Key words

cystectomy, prostatectomy, bladder cancer, prostate cancer, prostate-specific antigen.

References (14)

  1. National Cancer Registry – http://onkologia.org.pl/, online access 21.12.2014.
  2. National Cancer Registry – http://onkologia.org.pl/nowotwory-zlosliwe-gruczolu-krokowego-c61/, online access 21.12.2014.
  3. Rullis I, Schaffer JA, Lilien OM: Incidence of prostatic carcinoma in the elderly. Urology 1975, 6, 295.
  4. Bostanci Y, Kazzazi A, Djavan B: Optimizing prostate biopsy. Minerva Urol Nefrol 2012, 64, 233–243.
  5. National Cancer Registry – http://onkologia.org.pl/nowotwory-zlosliwe-pecherza-moczowego-c67/, online access 21.12.2014.
  6. Melicow MW, Uson AC: Multiple unrelated primary malignancies of the genitourinary tract. J Urol 1957, 77, 96–105.
  7. Lee SH, Phei-Lang C, Shao-Ming C, Sun GH, Chien LC, BiingYir S, Wu Y, Ke-Hung T: Synchronous primary carcinomas of the bladder and prostate. Asina J Androl 2006, 8, 357–359.
  8. Salminen E, Pukkala E, Teppo L: Subsequent primary cancers following bladder cancer. Eur J Cancer 1994, 30A, 303–307.
  9. Abbas F, Hochberg D, Civantos F, Soloway M: Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol 1996, 30, 322–326.
  10. Pritchett RT, Moreno J, Warner EN: Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J Urol 1988, 139, 1214–1216.
  11. Yumura Y, Oogo Y, Takase K, Kato Y, Hamano A, Noguchi S, Fukuda M, Satomi Y: Clinical analysis of double cancer involving bladder and prostate. Hinyokika Kiyo 2006, 52, 255–258.
  12. Sanli O, Acar O, Celtik M, Oktar T, Kilicaraslan I, Ozcan F, Tunc M, Esen T: Should prostate carncer status be determined in patients undergoing radical cystoprostatectomy? Urol Int 2006, 77, 307–310.
  13. Abdelhadey M, Abusamra A, Pautler SE, Chin J, Lizawa JI: Clinically significant prostate cancer found in radical cystoprostatectomy specimens. BJU Int 2007, 99, 326–329.
  14. Chun TY: Coincidence of bladder and prostate cancer. J Urol 1997, 157, 65–67.